BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31783876)

  • 1. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
    Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
    Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.
    Wang CI; Chien KY; Wang CL; Liu HP; Cheng CC; Chang YS; Yu JS; Yu CJ
    Mol Cell Proteomics; 2012 Nov; 11(11):1105-22. PubMed ID: 22843992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer.
    Xiang S; Wang Z; Ye Y; Zhang F; Li H; Yang Y; Miao H; Liang H; Zhang Y; Jiang L; Hu Y; Zheng L; Liu X; Liu Y
    Oncogene; 2019 Feb; 38(8):1269-1281. PubMed ID: 30254209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells.
    Wang CI; Chen YY; Wang CL; Yu JS; Chang YS; Yu CJ
    Oncotarget; 2016 May; 7(18):25432-42. PubMed ID: 27009856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.
    Zan Y; Wang B; Liang L; Deng Y; Tian T; Dai Z; Dong L
    J Exp Clin Cancer Res; 2019 May; 38(1):182. PubMed ID: 31046781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma.
    Hu ZY; Yuan SX; Yang Y; Zhou WP; Jiang H
    J Exp Clin Cancer Res; 2014 Jul; 33(1):61. PubMed ID: 25060425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1 and TFDP1 Regulate PITX1 Expression in Normal and Osteoarthritic Articular Chondrocytes.
    Pellicelli M; Picard C; Wang D; Lavigne P; Moreau A
    PLoS One; 2016; 11(11):e0165951. PubMed ID: 27802335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of nuclear KPNA2 is correlated with early recurrence and poor prognosis in patients with small hepatocellular carcinoma after hepatectomy.
    Jiang P; Tang Y; He L; Tang H; Liang M; Mai C; Hu L; Hong J
    Med Oncol; 2014 Aug; 31(8):131. PubMed ID: 25031071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F.
    Nakajima R; Deguchi R; Komori H; Zhao L; Zhou Y; Shirasawa M; Angelina A; Goto Y; Tohjo F; Nakahashi K; Nakata K; Iwanaga R; Bradford AP; Araki K; Warita T; Ohtani K
    Biochem Biophys Res Commun; 2023 Jun; 663():154-162. PubMed ID: 37141667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importin KPNA2 confers HIV-1 pre-integration complex nuclear import by interacting with the capsid protein.
    Song Y; Zhang H; Wang Y; Guo J; Tang S; Wang L; Peng K; Dong CS
    Antiviral Res; 2022 Apr; 200():105289. PubMed ID: 35301060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types.
    Guo X; Wang Z; Zhang J; Xu Q; Hou G; Yang Y; Dong C; Liu G; Liang C; Liu L; Zhou W; Liu H
    Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):285-292. PubMed ID: 30883648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction.
    Saito F; Araki K; Yokobori T; Ishii N; Tsukagoshi M; Watanabe A; Kubo N; Altan B; Shirabe K; Kuwano H
    J Surg Oncol; 2016 Sep; 114(4):462-8. PubMed ID: 27338241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation.
    Ma S; Zhao X
    Oncol Rep; 2014 Oct; 32(4):1631-7. PubMed ID: 25109899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
    Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
    Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomics reveals a novel role of karyopherin alpha 2 in cell migration through the regulation of vimentin-pErk protein complex levels in lung cancer.
    Wang CI; Wang CL; Wu YC; Feng HP; Liu PJ; Chang YS; Yu JS; Yu CJ
    J Proteome Res; 2015 Apr; 14(4):1739-51. PubMed ID: 25728791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.
    Wang CI; Yu CJ; Huang Y; Yi JS; Cheng HW; Kao HK; Lao WW; Chang KP
    Head Neck; 2018 Aug; 40(8):1719-1733. PubMed ID: 29542209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer.
    Ohhara Y; Kinoshita I; Suzuki A; Imagawa M; Taguchi J; Noguchi T; Takeuchi S; Shimizu Y; Seki H; Suzuki J; Dosaka-Akita H
    Oncology; 2022; 100(12):685-695. PubMed ID: 36273446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMMD9 promotes TFDP1/E2F1 transcriptional activity via interaction with TFDP1 in non-small cell lung cancer.
    Zhan W; Wang W; Han T; Xie C; Zhang T; Gan M; Wang JB
    Cell Signal; 2017 Jan; 30():59-66. PubMed ID: 27871936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.